FOXL2 Suppresses Proliferation, Invasion and Promotes Apoptosis of Cervical Cancer Cells

Overview

Journal Int J Clin Exp Pathol

Specialty Pathology

Date 2014 May 13

PMID 24817949

Citations 15

Authors

Xing-Long Liu

Yu-Han Meng

Jian-Li Wang

Biao-Bing Yang

Fan Zhang

Sheng-Jian Tang

Affiliations

Soon will be listed here.

Abstract

FOXL2 is a transcription factor that is essential for ovarian function and maintenance, the germline mutations of which give rise to the blepharophimosis ptosis epicanthus inversus syndrome (BPES), often associated with premature ovarian failure. Recently, its mutations have been found in ovarian granulosa cell tumors (OGCTs). In this study, we measured the expression of FOXL2 in cervical cancer by immunohistochemistry and its mRNA level in cervical cancer cell lines Hela and Siha by RT-PCR. Then we overexpressed FOXL2 in Hela cells and silenced it in Siha cells by plasmid transfection and verified using western blotting. When FOXL2 was overexpressed or silenced, cells proliferation and apoptosis were determined by Brdu assay and Annexin V/PI detection kit, respectively. In addition, we investigated the effects of FOXL2 on the adhesion and invasion of Hela and Siha cells. Finally, we analyzed the influences of FOXL2 on Ki67, PCNA and FasL by flow cytometry. The results showed that FOXL2 was highly expressed in cervical squamous cancer. Overexpressing FOXL2 suppressed Hela proliferation and facilitated its apoptosis. Silencing FOXL2 enhanced Siha proliferation and inhibited its apoptosis. Meanwhile, silencing FOXL2 promoted Siha invasion, but it had no effect on cells adhesion. In addition, overexpressing FOXL2 decreased the expression of Ki67 in Hela and Siha cells. Therefore, our results suggested that FOXL2 restrained cells proliferation and enhanced cells apoptosis mainly through decreasing Ki67 expression.

Citing Articles

IGF1R activates FOXP3-β-catenin signaling to promote breast cancer development.

Li L, Zhang Z, Huang N, Ren J, Qin Y, Luo Y Breast Cancer Res Treat. 2025; .

PMID: 40055251 DOI: 10.1007/s10549-025-07663-0.

Comparative transcriptomic analysis validates iPSC derived in-vitro progressive fibrosis model as a screening tool for drug discovery and development in systemic sclerosis.

Nathan S, Wang Y, Dambrosio M, Paul R, Lyu H, Delic D Sci Rep. 2024; 14(1):24428.

PMID: 39424619 PMC: 11489818. DOI: 10.1038/s41598-024-74610-2.

Upregulation of miR-20a-5p as the Potential MicroRNA Marker in Red Blood Cell Storage Lesion.

Rattanapan Y, Narkpetch S, Chareonsirisuthigul T Biomed Res Int. 2023; 2023:5598590.

PMID: 37829050 PMC: 10567411. DOI: 10.1155/2023/5598590.

Reduced RBPMS Levels Promote Cell Proliferation and Decrease Cisplatin Sensitivity in Ovarian Cancer Cells.

Rabelo-Fernandez R, Santiago-Sanchez G, Sharma R, Roche-Lima A, Carrion K, Noriega Rivera R Int J Mol Sci. 2022; 23(1).

PMID: 35008958 PMC: 8745614. DOI: 10.3390/ijms23010535.

New Regions With Molecular Alterations in a Rare Case of Insulinomatosis: Case Report With Literature Review.

Anoshkin K, Vasilyev I, Karandasheva K, Shugay M, Kudryavtseva V, Egorov A Front Endocrinol (Lausanne). 2021; 12:760154.

PMID: 34737724 PMC: 8563021. DOI: 10.3389/fendo.2021.760154.

References

Vijayachandra K, Higgins W, Lee J, Glick A . Induction of p16ink4a and p19ARF by TGFbeta1 contributes to growth arrest and senescence response in mouse keratinocytes. Mol Carcinog. 2008; 48(3):181-186. DOI: 10.1002/mc.20472. View

Matsuyama Y, Takao S, Aikou T . Comparison of matrix metalloproteinase expression between primary tumors with or without liver metastasis in pancreatic and colorectal carcinomas. J Surg Oncol. 2002; 80(2):105-10. DOI: 10.1002/jso.10106. View

Schuebel K, Chen W, Cope L, Glockner S, Suzuki H, Yi J . Comparing the DNA hypermethylome with gene mutations in human colorectal cancer. PLoS Genet. 2007; 3(9):1709-23. PMC: 1988850. DOI: 10.1371/journal.pgen.0030157. View

Benayoun B, Caburet S, Dipietromaria A, Georges A, Dhaene B, Eswari Pandaranayaka P . Functional exploration of the adult ovarian granulosa cell tumor-associated somatic FOXL2 mutation p.Cys134Trp (c.402C>G). PLoS One. 2010; 5(1):e8789. PMC: 2808356. DOI: 10.1371/journal.pone.0008789. View

Kim S, Kim H, Jong H, Park J, Kim N, Hong S . The endogenous ratio of Smad2 and Smad3 influences the cytostatic function of Smad3. Mol Biol Cell. 2005; 16(10):4672-83. PMC: 1237073. DOI: 10.1091/mbc.e05-01-0054. View

De Baere E, Dixon M, Small K, Jabs E, Leroy B, Devriendt K . Spectrum of FOXL2 gene mutations in blepharophimosis-ptosis-epicanthus inversus (BPES) families demonstrates a genotype--phenotype correlation. Hum Mol Genet. 2001; 10(15):1591-600. DOI: 10.1093/hmg/10.15.1591. View

Kim M, Hur S, Yoo N, Lee S . Mutational analysis of FOXL2 codon 134 in granulosa cell tumour of ovary and other human cancers. J Pathol. 2010; 221(2):147-52. DOI: 10.1002/path.2688. View

Jamieson S, Butzow R, Andersson N, Alexiadis M, Unkila-Kallio L, Heikinheimo M . The FOXL2 C134W mutation is characteristic of adult granulosa cell tumors of the ovary. Mod Pathol. 2010; 23(11):1477-85. DOI: 10.1038/modpathol.2010.145. View

Kalfa N, Philibert P, Patte C, Ecochard A, Duvillard P, Baldet P . Extinction of FOXL2 expression in aggressive ovarian granulosa cell tumors in children. Fertil Steril. 2007; 87(4):896-901. DOI: 10.1016/j.fertnstert.2006.11.016. View

10.

Tempia-Caliera A, Horvath L, Zimmermann A, Tihanyi T, Korc M, Friess H . Adhesion molecules in human pancreatic cancer. J Surg Oncol. 2002; 79(2):93-100. DOI: 10.1002/jso.10053. View

11.

Ellsworth B, Burns A, Escudero K, Duval D, Nelson S, Clay C . The gonadotropin releasing hormone (GnRH) receptor activating sequence (GRAS) is a composite regulatory element that interacts with multiple classes of transcription factors including Smads, AP-1 and a forkhead DNA binding protein. Mol Cell Endocrinol. 2003; 206(1-2):93-111. DOI: 10.1016/s0303-7207(03)00235-1. View

12.

Schmidt D, Ovitt C, Anlag K, Fehsenfeld S, Gredsted L, Treier A . The murine winged-helix transcription factor Foxl2 is required for granulosa cell differentiation and ovary maintenance. Development. 2004; 131(4):933-42. DOI: 10.1242/dev.00969. View

13.

Pannetier M, Fabre S, Batista F, Kocer A, Renault L, Jolivet G . FOXL2 activates P450 aromatase gene transcription: towards a better characterization of the early steps of mammalian ovarian development. J Mol Endocrinol. 2006; 36(3):399-413. DOI: 10.1677/jme.1.01947. View

14.

Cocquet J, De Baere E, Gareil M, Pannetier M, Xia X, Fellous M . Structure, evolution and expression of the FOXL2 transcription unit. Cytogenet Genome Res. 2003; 101(3-4):206-11. DOI: 10.1159/000074338. View

15.

Hanahan D, Bergers G, Bergsland E . Less is more, regularly: metronomic dosing of cytotoxic drugs can target tumor angiogenesis in mice. J Clin Invest. 2000; 105(8):1045-7. PMC: 300842. DOI: 10.1172/JCI9872. View

16.

Ottolenghi C, Pelosi E, Tran J, Colombino M, Douglass E, Nedorezov T . Loss of Wnt4 and Foxl2 leads to female-to-male sex reversal extending to germ cells. Hum Mol Genet. 2007; 16(23):2795-804. DOI: 10.1093/hmg/ddm235. View

17.

DAngelo E, Mozos A, Nakayama D, Espinosa I, Catasus L, Munoz J . Prognostic significance of FOXL2 mutation and mRNA expression in adult and juvenile granulosa cell tumors of the ovary. Mod Pathol. 2011; 24(10):1360-7. DOI: 10.1038/modpathol.2011.95. View

18.

Wegman P, Eremo A, Lindlof A, Karlsson M, Stal O, Wingren S . Expression of the forkhead transcription factor FOXL2 correlates with good prognosis in breast cancer patients treated with tamoxifen. Int J Oncol. 2011; 38(4):1145-51. DOI: 10.3892/ijo.2011.923. View

19.

Uda M, Ottolenghi C, Crisponi L, Garcia J, Deiana M, Kimber W . Foxl2 disruption causes mouse ovarian failure by pervasive blockage of follicle development. Hum Mol Genet. 2004; 13(11):1171-81. DOI: 10.1093/hmg/ddh124. View

20.

Schrader K, Gorbatcheva B, Senz J, Heravi-Moussavi A, Melnyk N, Salamanca C . The specificity of the FOXL2 c.402C>G somatic mutation: a survey of solid tumors. PLoS One. 2009; 4(11):e7988. PMC: 2777318. DOI: 10.1371/journal.pone.0007988. View